The weight-loss drug boom has entered a new phase. For several years, the most talked-about obesity medicines came as weekly injections. Now pills are catching up fast. A study published on 12 October 2026 in the Annals of Internal Medicine found that a daily semaglutide pill for weight management reached 100,000 new prescriptions a month within two months of its January 2026 US launch, much faster than the injectable versions, Medscape reported.
Here's what the research found, why pills matter and what anyone considering these medicines should keep in mind.
What the study found
Researchers led by Dr Yara Jelwan of the Johns Hopkins Ciccarone Center for Cardiovascular Disease Prevention analysed national data on new prescriptions filled at US retail pharmacies from July 2020 to June 2026. They compared the launch of the daily semaglutide pill with injectable semaglutide and injectable tirzepatide.
- Speed of uptake: The pill passed 100,000 monthly new prescriptions in 2 months. Injectable tirzepatide took 4 months and injectable semaglutide took 20 months.
- Steeper growth: Early prescriptions for the pill rose about 4.4 times faster than for injectable tirzepatide and 7.4 times faster than for injectable semaglutide.
- Not just switching: Prescriptions for injectable semaglutide didn't fall after the pill arrived, and total semaglutide prescriptions for weight loss rose.
"Oral formulations appear to reach additional patients," the study's authors wrote.
Why a pill makes a difference
The researchers noted that needle aversion, cost and access have held back the use of injectable GLP-1 medicines. A pill removes the injection barrier. For people who dislike needles, or who simply prefer a familiar tablet, that can make starting treatment feel much less daunting. The study's findings suggest the pill is bringing new people into treatment rather than just replacing injections.
Important limitations
The study has limits worth knowing:
- The data were aggregated, so researchers couldn't follow individual patients or see who switched between drugs.
- Off-label use couldn't be ruled out.
- The data didn't include insurance coverage, denied claims or cash payments, and didn't capture compounded versions of these drugs.
- One author reported consulting for and receiving grants from pharmaceutical companies, including the pill's manufacturer.
The study also looked at prescriptions, not outcomes. It tells us how quickly the pill caught on, not how much weight people lost or how long they stayed on it.
How GLP-1 medicines work, in brief
GLP-1 receptor agonists mimic a natural gut hormone involved in appetite and blood sugar control. They help people feel full sooner and for longer, and they slow how quickly the stomach empties. Originally developed for type 2 diabetes, several are now approved for weight management in many countries. Availability, approved uses and prices differ widely between countries.
What to consider if you're curious about these medicines
- Talk to a qualified clinician. These are prescription medicines with real side effects and specific eligibility criteria.
- Know the common side effects. Digestive symptoms such as nausea, constipation and diarrhoea are frequently reported, especially when starting or increasing the dose.
- Follow the instructions closely. Some oral medicines have specific rules about when and how to take them relative to food and drink. Your pharmacist can explain them.
- Protect your muscle and nutrition. When appetite drops, it's important to keep eating enough protein, fruit and vegetables, and to stay active, including some strength training.
- Think long term. Obesity is a chronic condition. Ask your clinician what happens if you stop, and how treatment fits into a long-term plan.
- Avoid unregulated sources. Buying weight-loss drugs online without a prescription carries real risks of counterfeit or contaminated products.
Medicines are one tool, not the whole toolkit
Even as medicines become more convenient, health authorities continue to stress the basics. In its first global guidelines on child and adolescent obesity, published the week before this study, the World Health Organization emphasised that structured support for diet, physical activity and behaviour change should be the foundation of care, with medicines considered for adolescents only when that support hasn't worked. The same principle applies to adults: medicines tend to work best alongside lasting changes to eating, movement and sleep.
Questions to ask your clinician
- Am I a suitable candidate, and is a pill or an injection better for me?
- What side effects should I expect, and which ones need urgent attention?
- How does this medicine interact with my other medicines or conditions?
- How will we measure success beyond the number on the scale?
- What's the plan if I need to stop, or if the cost changes?
Writing your questions down before an appointment helps you make the most of limited time.
Pills and injections: practical differences
Beyond the needle, there are practical differences to discuss with a clinician. Daily pills mean a daily routine, while some injections are weekly. Storage, travel, how the medicine is taken relative to meals, and cost can all affect which option suits your life.
What to watch next
More oral weight-loss medicines are in development, and researchers will be watching longer-term data on outcomes, how long people stay on treatment and whether pills widen access in practice. Cost and insurance coverage will largely decide how far that wider reach extends.
The takeaway
A daily pill has taken off faster than any injectable weight-loss drug before it, and appears to be reaching people the injections didn't. That's significant. But a quicker route to a prescription doesn't change the fundamentals: these are serious medicines that need medical supervision, and they work best as part of a broader, sustainable approach to health.
Note: This article is for general information and isn't a substitute for personalised medical advice.
